This activity has been designed to meet the educational needs of hepatologists, primary care providers, nurse practitioners/physician assistants, allied health care professionals, clinical pharmacists, and managed care decision makers.
At the conclusion of this activity, participants will be able to:
Identify the risk factors and symptoms of chronic liver disease
Discuss laboratory tests and invasive/noninvasive methodologies used to ascertain the underlying cause and classify the stage of disease
Describe screening and treatment for patients with cirrhosis/hepatocellular carcinoma
Apply the AASLD guidelines on screening, diagnosis, and treatment of patients infected with chronic hepatitis C
Recognize the safety and efficacy of currently available HCV therapies and those expected in the next 6 months and advise patients regarding treatment options based on their individual characteristics
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower, the Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-Hep). The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Program #0797-9999-14-126-L04-P. This program is designated for up to 3.5 contact hours (0.35 CEUs) of continuing pharmacy education credit.
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 3.5 contact hours may be earned for successful completion of this activity.
Provider is approved by the California Board of Registered Nursing, Provider # 13664, for 3.5 contact hours.
Disclosure of Conflicts of Interest:
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or en¬during material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc.; John Bayliss, VP, Business Development, partner is an employee of Amgen, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation have no relevant commercial relationships to disclose.
Learner Assurance Statement:
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
This is an invitation only. Submission of this form does not guarantee a seat at this meeting. Registration is confirmed on a first-come-first-served basis. Once your registration is processed, you will be notified regarding availability for this meeting.
Americans with Disabilities Act
The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.). Please contact us prior to the event at 888-565-5321.
This activity endorsed by the International Coalition of Hepatology Educational Providers and sponsored by the Chronic Liver Disease Foundation.
This activity Supported by:
AbbVie, Bayer Health Care Pharmaceuticals, Bristol-Myers Squibb, Janssen Therapeutics and Onyx Pharmaceuticals.